Welcome to Qatar Biobank
Qatar Biobank is a platform that will make vital health research possible through its collection of samples and information on health and lifestyle from large numbers of members of the Qatari population. Qatar Biobank, Qatar’s long-term medical health initiative, was created to give Qatar’s people better chances of avoiding serious illnesses, and to promote better health for our future generations.
You are being invited to take part in Qatar Biobank, Qatar’s long-term medical health initiative for Qatar’s population. To help you decide whether to contribute, here is some information on Qatar Biobank and what taking part involves.
Qatar Biobank will make it possible for scientists to conduct research to address some of the greatest health challenges facing Qatar and the region, including cardiovascular disease, obesity, diabetes, and cancer.
Qatar Genome Programme is an initiative that aims to use the latest DNA sequencing technology to establish a genome map of the local population.
17/07/17
Her Excellency Sheikha Hind bint Hamad Al Thani, Vice Chairperson and CEO of Qatar Foundation (QF), visited Qatar Biobank yesterday to receive an update on the organization’s current projects.
Read More About the News: H.E. SHEIKHA HIND VISITS QATAR BIOBANK
22/06/17
Qatar Biobank recently participated in the Garangao cultural celebration organized by Qatar Foundation for Education, Science and Community Development (QF).
01/03/17
The National Human Genome Research Institute defines genomic medicine as “an emerging medical discipline that involves using genomic information about an individual as part of their clinical care (e.g., for diagnostic or therapeutic decision-making) and the health outcomes and policy implications of that clinical use.”
28/02/17
Sidra’s research branch has opened three main labs and the state-of-the-art facilities have been brought into operation recently with high calibre expert teams from all over the world.
Read More About the News: Sidra's research branch opens three main labs
27/02/17
Scientists at The Wistar Institute in collaboration with Roswell Park Cancer Institute found a significant association between a rare genetic variant of the p53 gene present in African American women and their risk of developing breast cancer in premenopausal age.
 |
 |
 |
|
 |
 |
